Results 171 to 180 of about 76,145 (237)

Preventing resistance development in infections by OXA β-lactamase-producing Pseudomonas aeruginosa: correlating clinical outcomes with hollow-fibre model input. [PDF]

J Antimicrob Chemother
Montero MM, Fernández-Muñoz A, Domene-Ochoa S, Castañeda S, López-Montesinos I, Cortes-Lara S, Luque S, Colomar MA, Mulet X, López-Causapé C, Sorlí L, Padilla E, Horcajada JP, Oliver A.   +13 more
europepmc   +1 more source

AMR-GNN: a multi-representation graph neural network framework to enable genomic antimicrobial resistance prediction. [PDF]

Nat Commun
Nguyen HA, Peleg AY, Wisniewski JA, Wang X, Wang Z, Blakeway LV, Badoordeen GZ, Theegala R, Doan NQ, Parker MH, Green AG, Song J, Dowe DL, Macesic N.   +13 more
europepmc   +1 more source

Rivaroxaban and Piperacillin-Tazobactam: Case of Massive Gastrointestinal Bleeding. [PDF]

Case Rep Med
Mohammadi A, Bitarafan M, Saedian KH, Akhondi H.   +3 more
europepmc   +1 more source

An Unexpected Inverse Relationship Between Biofilm Formation and Antibiotic Resistance in Stenotrophomonas maltophilia. [PDF]

Antibiotics (Basel)
Pompilio A, Di Bonaventura G.
europepmc   +1 more source

Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infections. [PDF]

J Anesth Analg Crit Care
Gatti M, Grimaldi P, Rinaldi M, Siniscalchi A, Tonetti T, Viale P, Pea F.   +6 more
europepmc   +1 more source

A case of Chryseobacterium taklimakanense bacteremia. [PDF]

BMC Infect Dis
Tokano M, Tarumoto N, Imai K, Maeda T, Kobayashi T, Saito M, Maesaki S.   +6 more
europepmc   +1 more source

Peptide-based antimicrobial effect against carbapenem-resistant <i>Acinetobacter baumannii</i>: preclinical drug assessment and translational potential. [PDF]

Front Pharmacol
Lee HJ, Lee SJ, Sung YH, Park SM, Choi SP, Kim Y, Yoon YK.   +6 more
europepmc   +1 more source

Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion. [PDF]

Pharmaceutics
Trozzi I, Giorgi B, De Paola R, Gatti M, Pea F.   +4 more
europepmc   +1 more source

[Bacteremia secondary to <i>Campylobacter jejuni</i> pancolitis in an immunocompetent patient]. [PDF]

Rev Esp Quimioter
Sejas-Claros A, Cano-Pérez M, Sánchez-Borge BF, Lorenzo-Vidal B, Eiros-Bouza JM.   +4 more
europepmc   +1 more source

Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective. [PDF]

Infection
Röder J, Wingen-Heimann SM, Seidel D, Froitzheim AC, Kurte MS, Witzke O, Vehreschild MJGT, Cornely OA, Kron F.   +8 more
europepmc   +1 more source